Furthermore conditional deletion of MRE11 in B-lymphocytes prevented the development of IgH–MYC translocated lymphomas and triggered conspicuous DDR responses, suggesting that MRE11 counteracts MYC-induced RS [123]. The gene discussed is MRE11; the disease is lymphoma.